SHED vs MEDVi: Which GLP-1 Program Is Better in 2026?
By Weight Loss Provider Guide Editorial Team · Last verified April 18, 2026 · Full disclosure ↓
Independent comparison resource. We earn a commission on both SHED and MEDVi referrals. Where MEDVi wins, we say so plainly — see the conflict matrix below.
FDA Warning Letter on file for MEDVi: On February 20, 2026, the FDA issued MEDVi warning letter #721455 for website marketing language on compounded GLP-1 products. Read the full letter on FDA.gov →
The short answer: picked in 15 seconds
| Best if you want… | Choose |
|---|---|
| No-needle options (drops, lozenges, oral liposomal tablets) | SHED |
| Brand-name pathway incl. Foundayo pill, Wegovy pill/pen, Zepbound injection | SHED |
| Public all-50-state availability language | SHED |
| A 10% weight-loss guarantee (with participation requirements) | SHED |
| Lowest first-month price on semaglutide injection ($179, sometimes $149) | MEDVi |
| Month-to-month with no minimum term | MEDVi |
| FDA-approved medication billed through insurance | Neither — take the quiz |
Quick format comparison for self-pay adults. Compounded medications from both providers are not FDA-approved as finished products.
Provider-stated vs. what we actually verified
Every row is a claim one of these companies makes on its own site, checked against what the rest of that same site says — and what independent primary sources (FDA, public court filings, each provider’s legal terms) confirm.
| Claim | What they say | What we verified | Conflict? |
|---|---|---|---|
| MEDVi: "No membership or hidden fees" | Main GLP-1 landing pages | MEDVi's own brand-name product cards list $99 Membership + Medication Cost for Wegovy pill, Wegovy injection, and Zepbound injection | Yes — on MEDVi's own site |
| MEDVi: weight-loss guarantee | Marketing pages | Refund policy page states no guarantee of results or effectiveness; refunds limited to medical disqualification, damaged/incorrect items, or no weight loss in 5 months (minus 25% consultation fee) | Yes — marketing vs. refund-policy language |
| MEDVi: state availability | joinmedvi.com: "all 50 states"; glp.medvi.org terms: "certain states, contact us" | MEDVi's own properties contradict each other | Yes — on MEDVi's own sites |
| MEDVi: entry price | $179 on standard pages; $149 on a separate official promo page | Both are currently live on MEDVi's site | Yes — same brand, two prices |
| MEDVi: FDA enforcement status | N/A | FDA Warning Letter #721455, dated Feb 20, 2026 — website marketing language | Not a conflict — verified public record |
| SHED: "Month-to-month" (lozenges page) | GLP-1 lozenges product page | SHED's help center and legal terms both state a 2-month minimum before cancellation, plus 72-hour notice | Yes — on SHED's own site |
| SHED: brand-name membership price | Zepbound page: $99/month; Wegovy page: $125/month starting | Same brand-name pathway, two different published membership rates | Yes — on SHED's own site |
| SHED: state availability | Help center: "all 50 states, not Puerto Rico" | Consistent across SHED public pages checked | No conflict — one public answer |
Screenshot any pricing page at checkout. That screenshot is your receipt if a rate changes between intake and first charge. Checked April 18, 2026.
SHED vs MEDVi at a glance
Pricing verified against each provider’s own site on April 18, 2026. Promotional pricing changes. Reconfirm at checkout and save the page.
| Factor | SHED (tryshed.com) | MEDVi (medvi.org) |
|---|---|---|
| Compounded semaglutide — first month | $199 | $179 standard · $149 on current promo page |
| Compounded semaglutide — ongoing | $199/mo starting; $249/mo at maintenance dose | $299 listed (terms reserve right to vary by prescription and pharmacy) |
| Compounded tirzepatide injection | From $299/mo | $349 starting |
| Compounded tirzepatide tablet | Not publicly listed as of 4/18/26 | $279 starting |
| No-needle options | Drops ($229/mo), lozenges ($199/mo), oral semaglutide liposomal tablets | Oral tablets only |
| Brand-name pathway | Foundayo (oral, FDA-approved), Wegovy pill, Wegovy injection, Zepbound injection — membership + pharmacy pays separately ($99–$125/mo membership) | Wegovy pill, Wegovy injection, Zepbound injection — $99 membership + medication cost |
| Weight-loss guarantee | 10% body weight in 9 months — strict conditions (first-time user, weekly weigh-ins, monthly check-ins, coaching participation) | Refund if no weight loss in 5 months, minus 25% consultation fee. Refund policy states no guarantee of results or effectiveness. |
| Cancellation | 2-month minimum per help center and terms, then 72-hour notice before billing | Cancel anytime; 72-hour notice before billing date; no minimum term |
| State availability | All 50 states (not Puerto Rico) — consistent across public pages | Conflicting: joinmedvi.com says "all 50 states"; glp.medvi.org terms say "certain states, contact us" |
| HSA / FSA | ✅ Accepted per help center | ✅ GLP-1 pages marked "HSA/FSA Approved" |
| FDA enforcement | No current warning letter (verified 4/18/26); "clinically proven" marketing language on one page is a compliance risk flag | FDA Warning Letter #721455, Feb 20, 2026 — website marketing language |
| Named pharmacy partners | Strive Compounding Pharmacy, Promise Pharmacy, Foothills Professional Pharmacy (per legal terms) | Named partners differ between pages reviewed — confirm directly |
| Trustpilot | 4-star range; smaller review base | 4-star range; larger public review volume |
Which one fits you — SHED or MEDVi GLP-1?
SHED’s format menu includes injections, liquid drops, lozenges, and oral liposomal tablets — plus brand-name FDA-approved pill pathways. Compounded formats are not FDA-approved as finished products.
Pick SHED if any of these describe you
- You don't want injections and want real alternatives — drops, lozenges, or oral semaglutide liposomal tablets.
- You want access to Foundayo (orforglipron — the FDA-approved oral GLP-1 pill approved April 1, 2026) or Wegovy pill without switching providers.
- You want a public all-50-state answer in writing before you enter your payment info.
- A 10% weight-loss guarantee is meaningful to you, and you're willing to follow the participation rules.
- You're planning to commit for at least 2 months.
Pick MEDVi if any of these describe you
- You want the lowest first-month price you can find on a compounded semaglutide injection ($179 standard, $149 on the current promo page).
- You're fine with injections and don't need drops or lozenges.
- You want true month-to-month with no minimum term.
- You care more about large public review volume and 24/7 messaging than format variety.
Pick neither if this describes you
- You want only FDA-approved medication (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo) billed through your insurance.
- MEDVi's FDA warning letter is a dealbreaker for you and SHED's format breadth doesn't offset it.
- You need structured clinical coaching as the core of the program, not a side option.
Which is cheaper after the first month?
| Format | SHED | MEDVi | Notes |
|---|---|---|---|
| Compounded semaglutide injection — month 1 | $199 | $179 (sometimes $149 promo) | MEDVi cheaper on first month |
| Compounded semaglutide injection — ongoing | $199–$249/mo (maintenance) | $299 listed (may vary) | SHED cheaper at lower doses; MEDVi refill fixed (but terms allow variation) |
| Compounded tirzepatide injection | From $299/mo | $349 starting | SHED cheaper starting price |
| Compounded tirzepatide tablet | Not publicly listed as of 4/18/26 | $279 starting | MEDVi only — see oral tirzepatide litigation note |
| Semaglutide lozenges | $199/mo | Not offered | SHED only; cheapest no-needle option |
| Semaglutide drops | $229/mo | Not offered | SHED only |
| Semaglutide oral tablets (compounded) | Listed (price: verify at publish) | $249 first month, $369 refill | |
| Brand-name pathway (membership fee) | $99–$125/mo depending on product page + pharmacy cost separately | $99/mo + medication cost | SHED shows two rates on same pathway — screenshot your specific page |
Which one is easier to cancel?
SHED cancellation
- 2-month minimum commitment from subscription start
- 72-hour notice before next billing date on each renewal
- GLP-1 lozenges page uses “month-to-month” language — the terms are the binding document
- Screenshot the product page at checkout
MEDVi cancellation
- Cancel anytime per refund policy
- No minimum term
- 72-hour notice before billing date — confirm your exact billing cadence at checkout
- Set a calendar reminder the day you enroll
The guarantees — what they actually require
SHED’s 10% guarantee
To qualify for a refund, you must:
- Be a first-time GLP-1 user
- Complete weekly weigh-ins
- Complete monthly check-ins
- Participate in coaching / community
- Stay on the program for the full 9 months
Miss any requirement and the refund path closes.
MEDVi’s refund provision
Their refund policy explicitly states:
- No guarantee of results or effectiveness
- Refunds mainly tied to medical disqualification or damaged/incorrect items
- Separate provision: refund after 5 months with no weight loss, minus 25% consultation fee
Marketing language about a guarantee conflicts with the refund policy page.
Does SHED or MEDVi give me pills, lozenges, drops, or brand-name GLP-1s?
SHED’s format menu
- Sublingual drops ($229/mo)
- Dissolvable lozenges ($199/mo)
- Oral semaglutide liposomal tablets
- Semaglutide injection ($199/mo)
- Tirzepatide injection (from $299/mo)
- Foundayo® (orforglipron, FDA-approved Apr 1, 2026)
- Wegovy® pill + Wegovy® injection
- Zepbound® injection
MEDVi’s format menu
- Compounded semaglutide injection ($179/$299)
- Compounded semaglutide oral tablet ($249/$369)
- Compounded tirzepatide injection ($349+)
- Compounded tirzepatide oral tablet ($279+)
- Wegovy® pill ($99 membership + med cost)
- Wegovy® injection ($99 membership + med cost)
- Zepbound® injection ($99 membership + med cost)
- Foundayo® not listed on MEDVi pages (verify at publish)
- No drops or lozenges
If “I hate needles” is the entire reason you’re here, SHED’s lozenges at $199/month beat MEDVi’s oral tier on price and offer more than one non-injection format.
Red flags: what you should know before you click either one
MEDVi’s FDA Warning Letter — what the letter actually says
On February 20, 2026, the FDA issued MEDVi warning letter #721455. Three specific findings:
- MEDVi’s marketing implied MEDVi was the compounding pharmacy itself, when actual compounding is done by third-party partners
- Language that implied compounded products had FDA approval or evaluation (they do not)
- The letter addressed website content — it was not a finding on manufacturing, pharmacy inspection, or clinical harm
Industry context: The FDA announced 30 warning letters on March 3, 2026 against telehealth companies for illegal marketing of compounded GLP-1s. MEDVi’s letter preceded that announcement by two weeks. This is an industry-wide enforcement wave.
Read FDA Warning Letter #721455 on FDA.govMEDVi’s “no membership” vs. “$99 Membership + Medication Cost”
$99 Membership + Medication Cost. Both are live on MEDVi’s public pages. The “no membership” language applies to the compounded pathway; the $99 applies to brand-name. Know which program you’re enrolling in before entering payment info.MEDVi’s guarantee vs. refund-policy language
SHED’s 2-month minimum vs. “month-to-month” product-page language
SHED’s $99 vs. $125 brand-name membership
SHED’s “clinically proven ingredients” marketing language
Pharmacies, shipping, HSA/FSA, and state availability
State availability
SHED
Help center: all 50 states, excluding Puerto Rico. Consistent across public pages. Verified April 18, 2026.
MEDVi
Two MEDVi properties disagree: joinmedvi.com says “all 50 states”; glp.medvi.org terms say “certain states.” Ask support in writing before you enroll if your state matters.
Pharmacy partners
SHED names Strive Compounding Pharmacy, Promise Pharmacy, and Foothills Professional Pharmacy in its legal terms. Terms disclose that prescriptions may be transferred between partner pharmacies and certain products may ship from outside the U.S. depending on formulation.
MEDVi names partner pharmacies publicly, but the named partners differ between the pages reviewed. Pharmacy rotation is common in this space — if consistent pharmacy sourcing matters to you, ask MEDVi support directly.
HSA / FSA
Both providers publicly accept HSA/FSA cards. SHED’s help center confirms it; MEDVi’s GLP-1 pages are marked “HSA/FSA Approved.” Your plan administrator has final approval in both cases. See our SHED HSA/FSA guide for reimbursement tips.
What real customers say about SHED and MEDVi
Both providers hold Trustpilot ratings in the 4-star range. MEDVi has the larger public review base; SHED has a smaller but active one. Reviews are a signal on service texture — onboarding, communication, billing clarity — not medical efficacy.
“Very kind, informative & patient with my questions.”
— SHED Trustpilot review (EB, March 30, 2026). Support-logistics quote; individual weight-loss results vary.
“Quick and easy.”
— MEDVi Trustpilot review (Miranda N., April 17, 2026). Support-logistics quote; individual weight-loss results vary.
How to switch from SHED to MEDVi (or vice versa)
Cancel your current provider within that provider’s required window, complete a new intake at the new provider before canceling the old one, and plan a 1–2 week medication overlap so you don’t gap. Prescription history does not transfer automatically.
- Confirm your current provider’s cancellation window — 72 hours before billing at minimum.
- Save your last shipment documentation: dose, dispensing pharmacy, lot number if provided.
- Complete the new provider’s intake before canceling the current subscription.
- Plan 1–2 weeks of medication on hand for the transition.
- Ask your new prescriber about dose continuity — don’t assume they’ll match your prior dose.
Our final verdict
For most readers in 2026: SHED
Broader format flexibility, a brand-name pathway that includes Foundayo oral pill, public all-50-state language, no current FDA enforcement action, and a 10% weight-loss guarantee if you’ll follow the participation conditions. The 2-month minimum is the tradeoff — plan for it before you enroll.
Check SHED eligibility now →For price-sensitive injection buyers: MEDVi
$179 on compounded semaglutide injection (sometimes $149 on the promo page), $299 listed refill, and true month-to-month. You’ve now read the FDA warning letter in full context — decide with your eyes open.
See MEDVi’s current starter offer →Still not sure?
We’ll match you based on budget, injection preference, brand-name vs. compounded preference, cancellation-risk tolerance, and whether insurance matters. If SHED or MEDVi isn’t your fit, we’ll route you to the provider that is.
Start the 60-second matching quizOur methodology
We verified every pricing, policy, and regulatory claim against primary sources. Every data point is dated. We update this page monthly for pricing and quarterly for everything else, with immediate updates for material developments.
Sources checked on April 18, 2026
SHED: tryshed.com homepage and weight-loss category page, individual product pages (injections, lozenges, drops, oral liposomal tablets, Wegovy, Zepbound, Foundayo), help center (subscriptions, cancellation, FSA/HSA, state availability), legal terms and refund policy.
MEDVi: medvi.org main site and GLP-1 landing pages, joinmedvi.com, glp.medvi.org terms and refund policy, individual product cards (Wegovy pill, Wegovy injection, Zepbound).
Regulatory / legal: FDA warning letter #721455 (Feb 20, 2026), FDA press announcement on 30 telehealth warning letters (March 3, 2026), Fierce Healthcare reporting on OpenLoop / Triad Rx class action.
Reviews: Trustpilot profiles for both (30-day window), Reddit r/glp1 and r/tirzepatidecompound (90-day window).
Why our commission doesn’t steer the verdict
We earn a commission on both SHED and MEDVi referrals. If payout alone set our verdict, we’d push one provider for every reader. We don’t — MEDVi wins on first-month entry price and cancellation flexibility, and we say so plainly above.
What’s not on this page
No “medically reviewed by” line we haven’t earned. No star ratings we haven’t verified. No efficacy claims lifted from testimonials. No description of compounded medications as “clinically proven” or as having the “same active ingredient” as brand-name drugs — those are the exact claims drawing regulatory scrutiny across this industry.
Affiliate & editorial disclosure
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission if you enroll through some links on this page. Our editorial verdicts are based on verified evidence and reader fit; our commission relationships do not change which providers we recommend to whom.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. GLP-1 medications should be used only under the supervision of a licensed healthcare provider. Compounded medications are prepared by licensed pharmacies and are not FDA-approved as finished products. Individual weight-loss results vary; always discuss risks, benefits, and handling with your prescribing clinician before starting, switching, or stopping treatment.
Last verified: April 18, 2026. Updated monthly for pricing, quarterly for policies and regulatory items.
Frequently asked questions: SHED vs MEDVi GLP-1
This page is part of Weight Loss Provider Guide’s GLP-1 provider comparison series. Last verified April 18, 2026.